BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7833663)

  • 1. Differentiation of postpartum thyrotoxicosis by serum thyroglobulin: usefulness of a new multisite immunoradiometric assay.
    Hidaka Y; Nishi I; Tamaki H; Takeoka K; Tada H; Mitsuda N; Amino N
    Thyroid; 1994; 4(3):275-8. PubMed ID: 7833663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
    Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
    Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
    Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
    Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
    Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in antideoxyribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease.
    Tachi J; Amino N; Iwatani Y; Tamaki H; Mori M; Aozasa M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1049-53. PubMed ID: 3263380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
    Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
    Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
    Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
    Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
    Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
    Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
    Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory diagnosis before onset and prediction of Graves' disease].
    Hidaka Y; Tada H; Amino N
    Rinsho Byori; 1997 Sep; 45(9):825-30. PubMed ID: 9311254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
    Ide A; Amino N; Nishihara E; Kudo T; Ito M; Kimura Y; Tatsumi N; Yamazaki M; Miyauchi A
    Endocr J; 2016 Oct; 63(10):929-932. PubMed ID: 27432817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; MarinĂ³ M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis.
    Parkes AB; Black EG; Adams H; John R; Richards CJ; Hall R; Lazarus JH
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):9-14. PubMed ID: 8050135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy.
    Kawamura S; Kishino B; Tajima K; Mashita K; Tarui S
    J Clin Endocrinol Metab; 1983 Mar; 56(3):507-12. PubMed ID: 6185525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
    Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
    Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of thyroglobulin antibody detected by ultrasensitive enzyme immunoassay: a good parameter for immune surveillance in healthy subjects and for prediction of post-partum thyroid dysfunction.
    Tamaki H; Katsumaru H; Amino N; Nakamoto H; Ishikawa E; Miyai K
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):266-73. PubMed ID: 1424209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.